KRAS and ovarian cancer: We analyzed the messenger RNA level of KRAS in different cancer types using the Oncomine database and found that KRAS is highly expressed in breast cancer, kidney cancer, lung cancer, myeloma, ovarian cancer, pancreatic cancer, and sarcoma compared to normal samples (Figure 2A).